Market revenue in 2020 | USD 396.6 million |
Market revenue in 2028 | USD 821.5 million |
Growth rate | 9.5% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.76% in 2020. Horizon Databook has segmented the Japan chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Presence of well-established healthcare system and high adoption of advanced technology for early diagnosis and treatment of chronic diseases are expected to boost the market in the country. Furthermore, presence of CLIA manufacturers in the region and continuous R&D activities by them for the introduction of innovative CLIA solutions have significantly supported the market growth in Japan.
In February 2021, Japan-based Sysmex Corporation received manufacturing and marketing approval for its HISCL Influenza Assay Kit. This kit is intended to be used on HISCL-5000/HISCL-800 automated immunoassay systems based on CLIA technique.
Moreover, in November 2020, Sysmex received Japanese marketing approval for its new chemiluminescence enzyme immunoassay, HISCL SARS-CoV-2 Ag Reagent test kit. Furthermore, growing prevalence of chronic and infectious diseases in the country is anticipated to boost demand for CLIA solutions for early diagnosis, which is anticipated to propel the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into Japan chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account